Why Transcode Therapeutics (RNAZ) Stock Is Down 60% - Benzinga
TransCode Therapeutics, Inc. Common Stock · PHARMACEUTICAL PREPARATIONS · Now $5.44
-17% in 7d after detection
Post-detection moves
1h
—
1d
-1.1%
3d
+1.0%
7d
-17%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS